Killer Cells, more formally known as cytotoxic T lymphocytes (CTLs) or natural killer (NK) cells, are crucial components of the immune system, playing a central role in the body's defense against infected or abnormal cells. Cytotoxic T lymphocytes are a type of white blood cell that specifically targets and eliminates cells infected by viruses or those displaying abnormal proteins, such as cancer cells. These cells recognize antigens on the surface of target cells and release cytotoxic granules containing perforin and granzymes, inducing apoptosis or cell death. Natural killer cells, another subset of killer cells, possess innate cytotoxic capabilities, responding rapidly to infected or stressed cells without prior sensitization. Killer cells are instrumental in immune surveillance, patrolling the body to identify and eliminate threats. They contribute to the balance between immune response and self-tolerance, preventing the development of autoimmune conditions. Dysregulation of killer cell activity can have implications for various diseases, including viral infections, cancer, and autoimmune disorders. Immunotherapies harnessing the power of killer cells, such as adoptive cell transfer and checkpoint inhibitors, represent innovative approaches in cancer treatment. Understanding the intricate functions of killer cells is essential for advancing immunological research and developing targeted therapeutic strategies to combat a range of diseases.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy